FTRP News and Press, Field Trip Health Ltd. From 10/18/21

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations PR Newswire NEW YORK , Oct. 18, ...

The Drug Enforcement Agency ("DEA") is proposing to dramatically increase the legal production of psychedelic drugs to be used for research purposes, Marijuana Moment reports. The agency says in 2022, it is calling for a doubling of psilocybin and psilocyn production, a quadrupling of mescali...

Field Trip Health Ltd. To Present At The KCSA Psychedelics Virtual Investor Conference On October 13th PR Newswire TORONTO , Oct. 12, 2021 /PRNewswire/ -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), a leader in the development an...

Palm Beach, FL –October 11, 2021 – FinancialNewsMedia.com News Commentary – There is a high demand for more advanced products for the treatment and maintenance of severe mental disorders. Thus, pharmaceutical companies are investing a huge amount of money fo...

NetworkNewsWire Editorial Coverage : The fact that psychedelics is a nascent industry doesn’t seem to be discouraging savvy investors exploring the opportunities. A recent Fortune article noted that “despite being an industry in its early stages, the potential for psychedeli...

Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge in demand for alternative options to traditional mental health support have fueled...

TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) (" Field Trip "), today announced the voting results from its Annual General and Special Meeting of Shareholders held on Friday, September 24, 2021. A total of 59.09% of the i...

TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today announced it will participate in the H.C. Wainwright 23 rd Annual Global Investment Conference, ...

TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; NASDAQ: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today the lead indications for FT-104, its novel psychedelic compound in development, wil...

The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip’s medical teams for screening, prescribing and administration of ketamine. Training programs will pro...